Magnesium: The Quiet Deficiency Behind Cramps, Sleep, and Mood

A standard blood panel includes serum magnesium. For most adults, that number comes back in the reference range. The patient is reassured, the chart notes “normal,” and the question of magnesium status is considered closed. This is one of the more consequential measurement errors in routine primary care. Serum magnesium reflects roughly 1% of the body’s total magnesium pool, and it is defended so aggressively by homeostatic regulation that stores can be substantially depleted before the blood number moves. A normal serum magnesium does not rule out a magnesium problem. It rules out an advanced one.

What the Intake Data Says

The dietary reference intake for magnesium is 420 mg per day for adult men and 320 mg per day for adult women. The most recent NHANES cycles consistently show that roughly half of American adults consume less than the Estimated Average Requirement, which is the more useful public health threshold. Among women over 60, the figure climbs above 70% below the EAR. Among adolescents, the gap is similarly wide. The intake shortfall has been consistent across every survey cycle for the past two decades.

The reason is not exotic. Magnesium is concentrated in foods that Americans, on average, do not prioritize — leafy greens, legumes, whole grains, nuts, seeds, and dark chocolate. It is stripped during the refining of grains and is not routinely added back during enrichment. The shift from whole grain bread to refined white flour, which accelerated over the second half of the twentieth century, removed a major population source of magnesium without a meaningful replacement in the food supply. Processed foods, which now supply more than half of calories in the typical American diet, tend to be magnesium-poor regardless of their caloric density.

What Magnesium Actually Does

The mineral is a cofactor for more than 300 enzymatic reactions. That number is cited often enough that it has become a stand-in for explanation, but the underlying mechanism is worth stating plainly. Magnesium binds to ATP, which is the primary energy currency of the cell. Every reaction that requires ATP — which is to say, most of them — depends on magnesium availability. DNA and RNA synthesis, muscle contraction and relaxation, nerve signal transmission, glucose metabolism, protein assembly, and maintenance of intracellular potassium balance all depend on it.

This ubiquity is why magnesium deficiency does not produce a single clean clinical syndrome. It produces a diffuse, often subtle, and easily misattributed cluster of symptoms: muscle cramping and twitching, disrupted sleep, elevated resting heart rate, increased anxiety and irritability, worsened premenstrual symptoms, and impaired exercise recovery. Each can be explained by other things. Most are not worked up as potential magnesium issues because the serum test came back normal.

Gröber and colleagues (2015) laid out the clinical picture in Nutrients, reviewing conditions in which subclinical magnesium deficiency has been documented: type 2 diabetes, metabolic syndrome, migraine, cardiovascular disease, osteoporosis, and depression. The paper’s central argument is that chronic latent magnesium deficiency — normal serum, depleted intracellular stores — is far more common than acute clinical deficiency and is implicated in a set of conditions whose connection to the mineral is rarely considered in primary care.

The Sleep and Mood Connection

Two outcomes have received particularly focused study. The first is sleep. Magnesium modulates GABAergic neurotransmission and regulates the HPA axis, both of which influence sleep onset and maintenance. Clinical trials in older adults with primary insomnia have reported improvements in sleep latency, sleep efficiency, and subjective sleep quality with supplementation at doses between 300 and 500 mg per day, typically as magnesium citrate or glycinate. The effect is not large — it is not a replacement for a hypnotic — but it is consistent across studies and the safety profile is strong at the doses used.

The second is anxiety. Boyle, Lawton, and Dye published a systematic review in Nutrients (2017) examining magnesium supplementation on subjective anxiety and stress. Eighteen studies met the inclusion criteria. The pooled effect favored supplementation, with effect sizes ranging from small to moderate. The authors noted that the strongest effects appeared in populations with suboptimal magnesium status at baseline — which, given the intake data, describes a substantial fraction of the adult population. In populations that were replete at baseline, the effect was negligible. This pattern is mechanistically coherent: supplementation restores function in those who are depleted and does little for those who are not.

Inflammation and Insulin Sensitivity

Nielsen’s 2018 review in the Journal of Inflammation Research focused on the connection between magnesium status and chronic low-grade inflammation. Epidemiological data shows an inverse relationship between magnesium intake and C-reactive protein, a standard inflammatory marker. Mechanistic work suggests that magnesium deficiency contributes to NF-κB activation and the associated cytokine cascade. The clinical implication matters because chronic low-grade inflammation is itself a risk factor for insulin resistance, atherosclerosis, and several cancers. Magnesium supplementation in deficient populations has been shown to modestly improve insulin sensitivity, with effects most pronounced in adults with prediabetes and metabolic syndrome.

This does not elevate magnesium to a metabolic cure. It places it appropriately in the chain of upstream nutrients whose sustained deficiency contributes to conditions that are then treated pharmacologically downstream.

The Form Question

Over-the-counter magnesium is sold in multiple forms, and the marketing around the distinctions is often louder than the evidence supports. The clinical literature is reasonably clean on a few points:

• Magnesium oxide, the cheapest form, has notably lower bioavailability — typically under 10%. Most of the dose passes through the intestine unabsorbed, which is why magnesium oxide is effective as an osmotic laxative and largely ineffective at raising body stores.
• Magnesium citrate and magnesium glycinate (or bisglycinate) show substantially higher absorption in controlled bioavailability studies, commonly in the 25 to 40% range. Glycinate tends to be gentler on the gut at higher doses and is the form most often recommended when gastrointestinal tolerance is a concern.
• Magnesium threonate has been marketed aggressively for cognitive effects based on animal work suggesting enhanced brain penetration. Human data supporting a cognitive advantage over other forms is limited; the claim runs ahead of the evidence.

For a replete adult looking to stay replete, dietary sources are the appropriate intervention. For an adult working to correct a documented deficiency or address specific symptoms, glycinate or citrate at 200 to 400 mg of elemental magnesium per day, taken with food and ideally split across two doses, is the evidence-supported starting point.

The Food-First Case

The NIH fact sheet lists magnesium-rich foods in descending order: pumpkin seeds (156 mg per ounce), chia seeds (111 mg per ounce), almonds (80 mg per ounce), cooked spinach (78 mg per half cup), cashews (74 mg per ounce), black beans (60 mg per half cup), edamame, peanuts, oatmeal, brown rice, yogurt, dark chocolate. Adding two or three of these to a daily eating pattern closes the intake gap for most adults without the need for supplementation at all.

The practical framing that matters: the RDA is attainable from food with a small number of deliberate choices. The population shortfall is a consequence of food culture, not of the food supply being incapable of delivering the nutrient. Magnesium is the quiet deficiency because the symptoms are easily misattributed, the blood test is easily misread, and the dietary fix is easily postponed. None of those are scientific obstacles. They are behavioral ones.